Related Experiment Video

Updated: Mar 6, 2026

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.7K

What Is New in the miRNA World Regarding Osteosarcoma and Chondrosarcoma?

Gaia Palmini1, Francesca Marini2, Maria Luisa Brandi3

  • 1Department of Surgery and Translational Medicine, University of Florence, Florence 50134, Italy. gaia.palmini@unifi.it.

Molecules (Basel, Switzerland)
|March 9, 2017
PubMed

Insights

Non-coding RNAs (ncRNAs), particularly microRNAs (miRNAs), are crucial in skeletal sarcoma development. This review highlights their roles as tumor suppressors and oncogenes in osteosarcoma and chondrosarcoma.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Skeletal sarcomas like osteosarcoma and chondrosarcoma have poor prognoses despite aggressive treatments.
  • Non-coding RNAs (ncRNAs), including microRNAs (miRNAs), play significant roles in cellular processes and disease pathology.
  • miRNAs are increasingly recognized for their involvement in cancer progression.

Purpose of the Study:

  • To review recent advancements in understanding the role of microRNAs in skeletal sarcomas.
  • To summarize the functions of specific miRNAs as tumor suppressors or oncogenes in osteosarcoma and chondrosarcoma.

Main Methods:

  • Literature review of recent studies on microRNAs in skeletal sarcomas.
  • Analysis of identified microRNAs involved in osteosarcoma and chondrosarcoma tumorigenesis.

Main Results:

  • Identification of specific microRNAs influencing osteosarcoma and chondrosarcoma development.
  • Categorization of microRNAs as either tumor suppressors or oncogenes in these cancers.

Conclusions:

  • MicroRNAs are critical regulators in the tumorigenesis of osteosarcoma and chondrosarcoma.
  • Further research into miRNA functions could lead to novel therapeutic strategies for skeletal sarcomas.
Keywords:
chondrosarcomamiRNAsoncogeneosteosarcomatumour suppressor

More Related Videos

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

11.7K
Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

19.7K

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K